Analytical and clinical performance of a Chikungunya qRT-PCR for Central and South America.
Analytical and clinical performance of a Chikungunya qRT-PCR for Central and South America.
复制标题
DOI:
10.1016/j.diagmicrobio.2017.06.001
复制
发表时间:
2017-09
影响因子:
2.9
通讯作者:
Adams ER
中科院分区:
文献类型:
--
作者:
Edwards T;Del Carmen Castillo Signor L;Williams C;Larcher C;Espinel M;Theaker J;Donis E;Cuevas LE;Adams ER
Chikungunya was introduced into the Americas in 2015 causing a pandemic across the continent. Testing during the acute phase of infection relies on qRT-PCR, but available assays have a number of limitations. A qRT-PCR assay specific to the chikungunya E1 gene was designed using sequence data from contemporary strains. A probit analysis established the 95% limit of detection as 19.6 copies per reaction. We compared the assay with a US Centers for Disease Control (CDC) chikungunya qRT-PCR as the reference standard. The assay had a sensitivity and specificity of 98.4% and 100% in 90 samples retrospectively collected in Guatemala. In a further 74 febrile samples prospectively collected in Ecuador and Guatemala the test had a sensitivity and specificity of 100% and 98.4%, respectively. Sequencing the nsp4 gene of the discordant positive sample indicated the presence of chikungunya RNA, and mismatches to the primer binding sites of the CDC assay.
登录
查看更多内容
影响因子:
3.8
作者:
Santiago GA;Vergne E;Quiles Y;Cosme J;Vazquez J;Medina JF;Medina F;Colón C;Margolis H;Muñoz-Jordán JL
通讯作者:
Muñoz-Jordán JL
影响因子:
3.8
作者:
Yap, Grace;Pok, Kwoon-Yong;Ng, Lee-Ching
通讯作者:
Ng, Lee-Ching
影响因子:
4.8
作者:
Shrinet J;Jain S;Sharma A;Singh SS;Mathur K;Rana V;Bhatnagar RK;Gupta B;Gaind R;Deb M;Sunil S
通讯作者:
Sunil S
影响因子:
7
作者:
Peixoto, A;Monteiro, M;Veiga-Fernandes, H
通讯作者:
Veiga-Fernandes, H
影响因子:
2.7
作者:
Cecilia, D.;Kakade, M.;Shah, P. S.
通讯作者:
Shah, P. S.